DAISe™ Thrombectomy System
Acute Ischemic Stroke (Mechanical Thrombectomy)
InvestigationalActive
Key Facts
Indication
Acute Ischemic Stroke (Mechanical Thrombectomy)
Phase
Investigational
Status
Active
Company
About MIVI Neuroscience
MIVI Neuroscience is a private, pre-revenue medical device company founded in 2015 and headquartered in Eden Prairie, Minnesota. The company is developing the next generation of neurointerventional devices, with its lead investigational product being the DAISe™ Thrombectomy System, designed as a mechanical backstop to assist in clot retrieval and reduce distal embolization. MIVI's strategy is deeply collaborative, working closely with neurointerventionalists to identify and solve pressing clinical challenges in stroke treatment, particularly for difficult-to-treat distal occlusions. The company is in the development and regulatory phase, with its technology not yet commercially available.
View full company profile